Unknown

Dataset Information

0

Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.


ABSTRACT: Duchenne muscular dystrophy (DMD) is a lethal muscle-wasting disease currently without cure. We investigated the use of the PiggyBac transposon for full-length dystrophin expression in murine mesoangioblast (MABs) progenitor cells. DMD murine MABs were transfected with transposable expression vectors for full-length dystrophin and transplanted intramuscularly or intra-arterially into mdx/SCID mice. Intra-arterial delivery indicated that the MABs could migrate to regenerating muscles to mediate dystrophin expression. Intramuscular transplantation yielded dystrophin expression in 11%-44% of myofibers in murine muscles, which remained stable for the assessed period of 5 months. The satellite cells isolated from transplanted muscles comprised a fraction of MAB-derived cells, indicating that the transfected MABs may colonize the satellite stem cell niche. Transposon integration site mapping by whole-genome sequencing indicated that 70% of the integrations were intergenic, while none was observed in an exon. Muscle resistance assessment by atomic force microscopy indicated that 80% of fibers showed elasticity properties restored to those of wild-type muscles. As measured in vivo, transplanted muscles became more resistant to fatigue. This study thus provides a proof-of-principle that PiggyBac transposon vectors may mediate full-length dystrophin expression as well as functional amelioration of the dystrophic muscles within a potential autologous cell-based therapeutic approach of DMD.

SUBMITTER: Iyer PS 

PROVIDER: S-EPMC6079556 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.

Iyer Pavithra S PS   Mavoungou Lionel O LO   Ronzoni Flavio F   Zemla Joanna J   Schmid-Siegert Emanuel E   Antonini Stefania S   Neff Laurence A LA   Dorchies Olivier M OM   Jaconi Marisa M   Lekka Malgorzata M   Messina Graziella G   Mermod Nicolas N  

Molecular therapy : the journal of the American Society of Gene Therapy 20180202 4


Duchenne muscular dystrophy (DMD) is a lethal muscle-wasting disease currently without cure. We investigated the use of the PiggyBac transposon for full-length dystrophin expression in murine mesoangioblast (MABs) progenitor cells. DMD murine MABs were transfected with transposable expression vectors for full-length dystrophin and transplanted intramuscularly or intra-arterially into mdx/SCID mice. Intra-arterial delivery indicated that the MABs could migrate to regenerating muscles to mediate d  ...[more]

Similar Datasets

| S-EPMC4693504 | biostudies-literature
| S-EPMC8673537 | biostudies-literature
| S-EPMC6332113 | biostudies-literature
| S-EPMC4737162 | biostudies-literature
| S-EPMC7329342 | biostudies-literature
| S-EPMC6981178 | biostudies-literature
| S-EPMC9357048 | biostudies-literature
| S-EPMC6473733 | biostudies-literature
| S-EPMC7389749 | biostudies-literature
| S-EPMC4728433 | biostudies-literature